FDA Briefing Material for the June 9, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee

May 8, 2009 The U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee met June 9 and 10, 2009, to review the research on safety and effectiveness of Seroquel, Zyprexa, and Geodon with pediatric patients. During the meetings, the committee reviewed research presented by the companies and research complied by the FDA. This report includes extensive prescription data compiled by SDI. The prescription data is sorted by age, gender, year, and product . . .